Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.
Wood B, Wu D, Crossley B, Dai Y, Williamson D, Gawad C, Borowitz MJ, Devidas M, Maloney KW, Larsen E, Winick N, Raetz E, Carroll WL, Hunger SP, Loh ML, Robins H, Kirsch I.
Wood B, et al. Among authors: devidas m.
Blood. 2018 Mar 22;131(12):1350-1359. doi: 10.1182/blood-2017-09-806521. Epub 2017 Dec 28.
Blood. 2018.
PMID: 29284596
Free PMC article.
Clinical Trial.